SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001012975-16-001095
Filing Date
2016-03-17
Accepted
2016-03-17 20:44:52
Documents
1
Period of Report
2016-03-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 8570
  Complete submission text file 0001012975-16-001095.txt   11664
Mailing Address
Business Address
CRANDELL KEITH (Reporting) CIK: 0001219039 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36781 | Film No.: 161513971

Mailing Address
Business Address
BYBEE CLINTON (Reporting) CIK: 0001219043 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36781 | Film No.: 161513970

Mailing Address 8725 W Higgins Chicago IL 60631
Business Address 8725 W Higgins Chicago IL 60631 773-380-6600
Arch Venture Fund VII LP (Reporting) CIK: 0001402439 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-36781 | Film No.: 161513969

Mailing Address 8725 W. HIGGINS ROAD SUITE 290 CHICAGO IL 60631
Business Address 8725 W. HIGGINS ROAD SUITE 290 CHICAGO IL 60631 773-380-6600
ARCH Venture Partners VII, LLC (Reporting) CIK: 0001544443 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36781 | Film No.: 161513972

Mailing Address 8725 W. HIGGINS ROAD SUITE 290 CHICAGO IL 60631
Business Address 8725 W. HIGGINS ROAD SUITE 290 CHICAGO IL 60631 773-380-6600
ARCH Venture Partners VII, L.P. (Reporting) CIK: 0001544444 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36781 | Film No.: 161513968

Mailing Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109
Business Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109 2066960703
Juno Therapeutics, Inc. (Issuer) CIK: 0001594864 (see all company filings)

IRS No.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)